Context
Monthly Round-Up
There are no new Professional Services Review (PSR) outcomes to report this month.
However, recent developments around the world demonstrate that fraud, waste and abuse follow public health funding wherever it flows — whether through insurance payments, eligibility rules, prescribing systems or insurer governance.
Payment integrity is not confined to Australia’s PSR process. It is a global discipline, and the lessons are increasingly transferable.
FWA Around the World
Recent enforcement actions in the Dominican Republic, United States, and China highlight how payment integrity risks manifest across very different health systems — but with strikingly similar failure points: weak governance, poor documentation, and insufficient oversight. Dominican Republic — Health Insurance Corruption Crackdown A judge has ordered pre‑trial detention for seven former officials linked to a US$250 million corruption scheme involving the Dominican Republic’s National Health Insurance agency. Allegations include bribery, fraudulent contracting, and billing for services never provided — conduct that directly impacted millions of insured citizens. The case has drawn widespread public attention and signals a renewed focus on corruption within national health financing institutions, particularly where insurer governance and contracting oversight are weak. Why it matters: National health insurers concentrate enormous purchasing power. When transparency, audit controls and separation of duties fail, corruption can scale rapidly and remain hidden for years. 📖 Read the original report here United States (Texas) — Medicaid Fraud Allegations and Record Falsification In a first‑of‑its‑kind action, Texas authorities have charged doctors with Medicaid fraud over alleged falsification of medical records to obtain payment for services that were not legally billable under state law. From a payment‑integrity perspective, the case is notable because it turns not on clinical judgement, but on documentation integrity, eligibility, and the lawful basis for claiming public funds. The allegations underscore how inaccurate or manipulated records undermine the legal foundations of public reimbursement. Why it matters: Public payment systems rely on truthful records. Where documentation fails, the entitlement to payment collapses — regardless of clinical intent. 📖 Read the original report here China — Intensified Oversight of Prescribing and Insurance Claims Chinese regulators have launched a renewed enforcement push targeting excessive prescribing, abnormal claim patterns, and pharmaceutical inducements. Using data‑driven “intelligent supervision,” authorities are monitoring prescription volumes, insurer losses, and collusion between providers and suppliers. The crackdown places renewed governance pressure on both domestic and multinational health and pharmaceutical organisations operating within China’s insurance frameworks. Why it matters: Large‑scale data surveillance is rapidly becoming the norm. Systems that cannot withstand real‑time scrutiny of prescribing and claiming behaviour face escalating regulatory and financial risk. 📖 Read the regulatory analysis here Global Takeaways- 💸 Fraud follows the funding. Whether money flows through insurance benefits, eligibility rules or prescribing systems, exploitation follows scale.
- 📄 Documentation is foundational. Across jurisdictions, record integrity remains central to lawful payment.
- 📊 Data‑driven enforcement is accelerating. Real‑time analytics and anomaly detection are fast becoming standard regulatory tools.
- 🏛️ Governance matters as much as billing. Weak insurer and system governance creates systemic vulnerability.
